Injectable fat dissolvers for double chin: what is known

The double chin is one of the concerns that brings the most patients to the office, and the "enzymatic" treatment has become the popular answer. Behind the nickname there is a group of injectable lipolytic substances that act on submental fat, with limited reach and risks of their own. This page summarizes what is known, at review level, without indicating injection technique.

Any decision about product, indication and approach belongs to the qualified professional, according to the package insert, the product's registration with ANVISA (Brazil's health regulator) and the rules of their professional council. For the concern from the patient's perspective, see enzymatic double chin lipo.

What is submental fat?

The area under the chin holds the pre-platysmal fat (between the skin and the platysma muscle) and, deeper, the subplatysmal fat. The term submental fat describes this compartment, and it is the one usually targeted by lipolytics.

The visible "double chin," however, is rarely just fat. It can involve:

• laxity of the skin and platysma;
• platysmal bands;
• position of the jaw and hyoid bone;
• retrogenia, which reduces space and pushes tissue downward;
• bulky or ptotic submandibular glands;
• weight gain and genetic predisposition.

That is why assessing the double chin comes before choosing the tool. Injecting a lipolytic in someone who mainly has laxity tends to disappoint.

How do they work and what is known?

The general mechanism described for this group is injury to fat cells, which the body clears through an inflammatory response. Some products are molecules that rupture the cell membrane; others are combinations of different ingredients, whose literature is more heterogeneous.

On the evidence, caution and honesty are in order:

• The available literature shows differences between the substances, in number of sessions, volume per session and assessment criteria.
• There is great variation between products, and some formulas used in the aesthetic setting do not have the same level of proof.
• Not every product on the market is registered for this use. The professional should check the health registration and the indication in the package insert, and treat off-label use as off-label, with specific consent.

To read that literature critically, see how to read a clinical trial and how to look up an injectable's registration at ANVISA.

How does it compare with other options?

The comparison does not pick a winner: it shows that each concern has its tool. Patients with a combination of fat and laxity may need a staged plan, or a referral. The text double chin: threads, biostimulator or enzymatic covers this choice from the patient's point of view.

What to expect in terms of swelling, pain and recovery?

The inflammatory response is the basis of the mechanism, which means swelling, pain and tenderness are expected. The intensity varies. The practical point is to prepare the patient and the schedule.

This timeline is illustrative. The professional should explain the expected course and the signs that call for an immediate return. Care of swelling and bruising afterward is part of the guidance, and the post-procedure instructions serve as a base.

What are the risks?

The submental region has delicate anatomy, and destroying fatty tissue is an inflammatory event. Among the risks cited:

• Injury to the marginal mandibular branch, with asymmetry of the lower smile. The marginal mandibular branch and the facial nerve are structures to respect. See nerve injury with injectables.
• Hematomas and ecchymosis, frequent in a well-vascularized region.
• Nodules and hardening, from residual inflammatory reaction.
• Ulceration and skin necrosis, rare but serious. See skin necrosis: course and care.
• Infection, which requires recognition and action.
• Unsatisfactory result, when the indication was inadequate.

Who should be assessed with more care?

Patients with a tendency to abnormal healing, autoimmune diseases, anticoagulant use, active infection in the area, pregnancy or breastfeeding, disproportionate expectations and a history of previous procedures in the area require cautious assessment and, in some cases, contraindication. The same goes for anyone with an important event in the coming days, because of the swelling. See also general contraindications in HOF and anticoagulants and injectable procedures.

How to handle the consent conversation?

Consent should be specific: the patient needs to know that swelling is expected and can be pronounced, that additional sessions may be needed, that results vary, that rare and serious risks exist and that the product may or may not be registered for this use. All of this information should be in the informed consent and in the patient record.

Indication checklist

How does Harmy fit into the conversation?

Harmy does not simulate submental fat reduction, because it works by adding volume to the marked areas. If the patient asks to "remove the double chin," explain that the projection does not show that effect. The app can support another part of the consultation, such as showing the effect of a more projected chin on the balance of the lower third, using the Chin point and the Jawline point.

Review quiz

Injectable lipolytics have a place, but a narrow one: localized fat, good skin, an informed patient and a professional who recognizes the risk. Outside that profile, the best decision is usually another tool, or none.